Tonix Pharmaceuticals Holding Corp Sustainability Reports
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing, licensing, and commercializing therapeutics to treat and prevent human diseases. Its portfolio primarily targets central nervous system disorders, immunology conditions, and infectious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900ACPKP9QW20GX48
FIGI: BBG001T49NZ9
5 reports from 2011 to 2024